DVN

Devon Energy

$51.23

-0.79%
Oct 27, 2026
Bobby Quantitative Model
Devon Energy Corporation is an independent U.S. oil and gas exploration and production company focused on shale assets, with roughly two-thirds of production from the Permian Basin and additional positions in the Anadarko, Eagle Ford, and Bakken basins; at year-end 2025 it reported net proved reserves of 2.4 billion barrels of oil equivalent and net production of about 840,000 boe/d at a 73% oil/NGL mix. Devon is a large-cap pure-play upstream operator (approximately $23 billion market cap, only ~2,200 employees) whose competitive identity rests on premium Permian inventory depth, low-cost operations, and a cash-return model rather than integrated downstream scale. The current investor narrative is dominated by portfolio reshaping and consolidation: a pending merger with Coterra that would add a gas-driven Appalachian foothold, a $4.5 billion Eagle Ford asset sale process that BP reportedly walked away from, and incremental Permian acreage acquired in a federal lease sale. Sentiment has also been lifted by geopolitical oil-price spikes tied to U.S.-Iran tensions and a broader rotation into energy value stocks, with sell-side analysts maintaining a strongly bullish stance even as the failed Eagle Ford sale complicates the deleveraging and activist-return story.

People also watch

ConocoPhillips

ConocoPhillips

COP

Analysis
EOG Resources

EOG Resources

EOG

Analysis
Occidental Petroleum

Occidental Petroleum

OXY

Analysis
Diamondback Energy

Diamondback Energy

FANG

Analysis
EQT

EQT

EQT

Analysis

BobbyInvestment Opinion: Should I buy DVN Today?

Rating: Buy. The core thesis is that Devon offers deep value on cash flow and asset metrics (EV/EBITDA 4.02x, PS 1.34x, PB 1.48x) with a strongly bullish analyst consensus (26 analysts, mean rating 1.25, average target $61.50 implying +19.7% upside) and powerful momentum (+53.68% over one year), making it an attractive energy value play despite near-term cash flow pressures. The analyst consensus 'strong_buy' and average target of $61.50 anchor the view that the risk/reward is skewed positively.

Supporting evidence: (1) Valuation is undemanding: EV/EBITDA of 4.02x is at the low end of the historical 12.5x-32.0x band, and PS of 1.34x is far below the 4.6x-9.3x range from 2022-2025. (2) Revenue growth of 73.13% YoY in Q2 2026, though merger-driven, demonstrates scale and cash-generating capacity. (3) Profitability is healthy with a 25.77% net margin and 17.01% ROE, and the dividend yield of 2.69% is well covered by a 23.4% payout ratio. (4) The implied upside to the analyst average target is +19.7%, with a high target of $74.00 (+44.0%).

Risks and conditions: The biggest risks are negative free cash flow (-$373 million in Q2 2026), a current ratio below 1.0, and the failed Eagle Ford sale that complicates deleveraging. The rating would upgrade to Strong Buy if free cash flow turns positive and the Eagle Ford asset sale is completed at a favorable price, or downgrade to Hold if oil prices fall below $70/bbl or if the Coterra merger integration disappoints. Valuation verdict: The stock is fairly valued to slightly undervalued relative to its own history on cash flow and asset metrics, but not deeply discounted on forward earnings; the re-rating case depends on oil prices and merger execution.

Sign up to view all

DVN 12-Month Price Forecast

The forward-looking view is bullish, supported by deep value on cash flow metrics, a strongly bullish analyst consensus, and powerful momentum. However, confidence is medium due to negative free cash flow, thin liquidity, and the failed Eagle Ford sale, which complicate the deleveraging story. The base case (50% probability) sees the stock trading between $52.71 and $61.50 as oil prices stabilize and merger integration proceeds. An upgrade to high confidence would require positive free cash flow and completion of asset sales; a downgrade to neutral would occur if oil prices fall below $70/bbl or if the Coterra merger encounters significant integration issues.

Historical Price
Current Price $51.23
Average Target $57.11
High Target $74.00
Low Target $31.65

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Devon Energy's 12-month outlook, with a consensus price target around $61.58 and implied upside of +20.2% versus the current price.

Average Target

$61.58

0 analysts

Implied Upside

+20.2%

vs. current price

Analyst Count

—

covering this stock

Price Range

$44 - $74

Analyst target range

Coverage is deep and overwhelmingly bullish: 26 analysts follow Devon with a consensus recommendation of "strong_buy" and a mean rating of 1.25 (where 1.0 is a strong buy). The average target price is $61.50, implying roughly +19.7% upside from the current $51.39, and consensus 2026 EPS estimates of $5.31 (range $4.26-$6.34) against a forward PE of 9.46x suggest the Street expects earnings well above the trailing run-rate. Estimated average revenue of $23.71 billion (range $20.10-$27.25 billion) also implies analysts are underwriting the enlarged post-merger production base.

Target dispersion is wide, from a low of $44.00 (about -14.4% downside) to a high of $74.00 (about +44.0% upside), a roughly 68% spread that signals meaningful disagreement on oil-price assumptions and merger outcomes. The high target likely assumes sustained elevated crude prices, successful Coterra integration, and a value-accretive Eagle Ford or Permian transaction, while the low target appears to price in weaker commodity realizations, margin compression, and disappointment on asset sales after BP's withdrawal. Institutional ratings show no downgrades in the recent tape — Wells Fargo, UBS, Raymond James, Citigroup, Barclays, Argus, Truist, and Susquehanna all reiterated Overweight/Buy/Strong Buy/Positive between July and September 2026 — indicating stable conviction, though the absence of fresh upgrades suggests the bullish case is already well reflected in the price near its 52-week high.

Drowning in data?

Find the real signal!

Bulls vs Bears: DVN Investment Factors

The bull case currently has stronger evidence: deep value on cash flow (EV/EBITDA 4.02x), a strongly bullish analyst consensus (26 analysts, mean rating 1.25, average target $61.50 implying +19.7% upside), and powerful momentum (+53.68% over one year, relative strength +40.55 points vs. SPY). However, the bear case is not trivial: negative free cash flow of -$373 million in Q2 2026, a current ratio below 1.0, and the failed Eagle Ford sale complicate the deleveraging story. The single most important tension is whether Devon can restore positive free cash flow and execute on asset sales and merger synergies to justify the stock's extended valuation near its 52-week high. If oil prices remain elevated and the Coterra integration delivers, the bull case prevails; if commodity prices soften or asset sale proceeds disappoint, the stock could retrace toward its $40-$42 support base.

Bullish

  • Analyst consensus strongly bullish with 19.7% upside: 26 analysts rate DVN a 'strong_buy' with a mean rating of 1.25 and an average target price of $61.50, implying +19.7% upside from $51.39. The high target of $74.00 implies +44.0% upside, and no downgrades were issued between July and September 2026.
  • Deep value on cash flow and asset metrics: EV/EBITDA of 4.02x sits at the low end of the historical 12.5x-32.0x band, while PS of 1.34x is far below the 4.6x-9.3x range from 2022-2025 and PB of 1.48x is near the low end of its 0.93x-4.17x multi-year band. This suggests the market is not paying a rich multiple for current cash earnings or reserves.
  • Strong momentum and relative leadership: DVN is up 53.68% over the past year and 35.70% YTD, with relative strength versus SPY of +40.55 points over one year and +24.25 points YTD. The stock sits at 97.5% of its 52-week range ($31.65-$52.71), just 2.5% below the high, signaling sustained trend leadership.
  • Low beta supports risk-adjusted positioning: Beta of 0.536 implies roughly 46% less volatility than SPY, unusually low for an upstream E&P name. This supports larger position sizing on a risk-adjusted basis and makes the stock attractive for investors seeking energy exposure with lower portfolio volatility.

Bearish

  • Negative free cash flow and thin liquidity: Q2 2026 operating cash flow of $3.674 billion was more than consumed by $4.047 billion of capex, producing negative free cash flow of -$373 million. The current ratio of 0.980 is below 1.0, signaling thin short-term liquidity and reliance on external capital or asset sales.
  • Earnings volatility and forward PE above trailing: Quarterly EPS swung from $0.19 in Q1 2026 to $2.04 in Q2 2026, and the forward PE of 9.46x is above the trailing PE of 8.70x, implying the market expects earnings to normalize lower from the elevated Q2 level. The negative PEG ratio of -1.10 reflects the absence of a clean earnings-growth trajectory.
  • Failed Eagle Ford sale weakens deleveraging story: BP reportedly walked away from a $4.5 billion Eagle Ford asset sale, weakening Devon's negotiating position with activist investors and complicating the deleveraging and cash-return narrative. This raises uncertainty around funding growth without leaning on external capital.
  • Extended near 52-week high, vulnerable to profit-taking: At $51.39, the stock is just 2.5% below its 52-week high of $52.71 after a 53.68% one-year run. The 22.7% max drawdown over the trailing period shows the path has not been linear, and the stock is vulnerable to profit-taking near prior highs.

DVN Technical Analysis

Devon is in a sustained uptrend: the stock is up 53.68% over the past year and 35.70% year-to-date, and at $51.39 it sits at roughly 97.5% of its 52-week range of $31.65 to $52.71, just 2.5% below the high. That positioning signals strong momentum and relative leadership rather than deep value — relative strength versus SPY is +40.55 percentage points over one year and +24.25 points YTD — but it also means the stock is extended and vulnerable to profit-taking near the prior high. The 22.7% max drawdown over the trailing period shows the path has not been linear despite the powerful annual gain.

Short-term momentum is accelerating and confirming the longer-term trend rather than diverging from it: the stock gained 6.97% in the past month and 14.10% over three months, both well ahead of SPY's -1.02% and +2.85%, producing relative strength of +7.99 and +11.25 points respectively. The latest session was especially forceful, with a 4.49% single-day advance from $49.18 to $51.39 on volume of about 13.3 million shares, pushing the price back to the top of the 180-day range. The one soft spot is the six-month window, where the 7.20% gain only marginally beat SPY's 6.45% (+0.75 points relative), implying the strongest thrust has come in the last quarter after a mid-year consolidation between roughly $40 and $45.

Key technical levels are well defined: resistance sits at the 52-week high of $52.71, and a decisive breakout above that level would confirm the uptrend and likely invite momentum and trend-following buyers, while support rests at the 52-week low of $31.65, with the $40-$42 area (the July 2026 base) acting as the more relevant intermediate floor. A breakdown below that base would signal trend failure and shift the setup toward a deeper mean-reversion move. Volatility is unusually low for an upstream E&P name — beta of 0.536 implies roughly 46% less volatility than SPY — which supports larger position sizing on a risk-adjusted basis, though the 2.18 short ratio and 22.7% max drawdown remind investors that commodity-driven gap risk remains.

Beta

0.54

0.54x market volatility

Max Drawdown

-22.7%

Largest decline past year

52-Week Range

$32-$53

Price range past year

Annual Return

+55.6%

Cumulative gain past year

PeriodDVN ReturnS&P 500
1m+8.9%-0.2%
3m+15.2%+5.5%
6m-0.3%+7.1%
1y+55.6%+12.3%
ytd+35.3%+12.9%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

DVN Fundamental Analysis

Revenue is inflecting sharply upward, though the optics are distorted by the pending Coterra combination: Q2 2026 revenue reached $7.417 billion, up 73.13% year-over-year from $4.284 billion in Q2 2025, with the leap driven largely by a jump in share count from 635 million to 937 million and a consolidated NGL product sales line of $5.106 billion. Sequentially, revenue rose from $3.807 billion in Q1 2026 and $4.121 billion in Q4 2025, but the underlying trend is uneven — Q1 2026 revenue of $3.807 billion was actually below Q1 2025's $4.452 billion, and Q2 2025 through Q1 2026 ranged between $3.8 billion and $4.3 billion. The takeaway is that headline growth reflects deal-driven scale and commodity realizations rather than organic volume acceleration, so investors should focus on per-share and per-boe metrics when the merger closes.

Profitability swung violently between quarters: Q2 2026 net income was $1.911 billion (EPS $2.04) on a 55.95% gross margin and 25.77% net margin, versus Q1 2026 net income of just $120 million (EPS $0.19) on a 12.14% gross margin and 3.15% net margin. The Q1-to-Q2 margin expansion is extreme and points to hedging, derivative, or one-time items rather than a smooth operating improvement — Q1 2026 operating income was $312 million versus $2.559 billion in Q2. Against the trailing-year baseline, gross margin of 25.55%, operating margin of 22.43%, and net margin of 15.37% are healthy for upstream E&P but below the 2022-2023 cycle peaks (gross margins of 40%+), consistent with a mid-cycle commodity backdrop.

Balance sheet and cash flow are the pressure point: debt-to-equity is a manageable 0.566 and ROE is a strong 17.01%, but the current ratio of 0.980 is below 1.0, signaling thin short-term liquidity. Q2 2026 operating cash flow of $3.674 billion was more than consumed by $4.047 billion of capital expenditure, producing negative free cash flow of -$373 million and a TTM FCF of just $1.674 billion against a $23.0 billion market cap (roughly 7.3% FCF yield). The company returned cash aggressively — $366 million of dividends and $197 million of buybacks in Q2 — while repaying $500 million of debt, and the 2.69% dividend yield with a 23.4% payout ratio remains well covered, but the negative quarterly FCF and sub-1.0 current ratio mean the Eagle Ford divestiture proceeds and merger synergies matter for funding growth without leaning on external capital.

Quarterly Revenue

$7.4B

2026-06

Revenue YoY Growth

+73.1%

YoY Comparison

Gross Margin

56.0%

Latest Quarter

Free Cash Flow

$1.7B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

N G L Product Sales

Open an Account, get $2 TSLA now!

Valuation Analysis: Is DVN Overvalued?

Because Devon is profitable (Q2 2026 net income of $1.911 billion; trailing EPS positive), the PE ratio is the appropriate primary metric. The stock trades at 8.70x trailing earnings but only 9.46x forward earnings — a forward multiple above the trailing one, which is unusual and implies the market expects earnings to normalize lower from the elevated Q2 2026 level rather than grow, consistent with the lumpy quarterly EPS pattern ($0.19 in Q1 2026 versus $2.04 in Q2). On cash flow the picture is cheaper, with price-to-operating-cash-flow around 10.5x and EV/EBITDA of 4.02x, while the 1.34x PS ratio and 1.48x PB ratio are modest for a large-cap producer.

Peer comparison is constrained because the provided valuation dataset contains no explicit industry-average multiples, so a precise premium/discount spread cannot be quantified — Data not available for sector averages. Relative to the stock's own history, however, the current 8.70x trailing PE is mid-range: it is above the 5.06x recorded at Q2 2026 and the 5.60x at Q2 2025, but far below the 66.2x at Q1 2026 (a depressed-earnings quarter) and the 12.1x-13.4x levels seen in early 2024. The 4.02x EV/EBITDA is toward the low end of the historical 12.5x-32.0x enterprise-value-multiple band, suggesting the market is not paying a rich multiple for current cash earnings.

Historical context reinforces a mixed read: the PS ratio of 1.34x is dramatically below the 4.6x-9.3x range that prevailed from 2022 through 2025, and PB of 1.48x is near the low end of its multi-year 0.93x-4.17x band, both of which argue the stock is cheap on sales and book value. Yet the dividend yield of 2.69% is above its historical 0.65%-2.18% range, and the negative PEG ratio of -1.10 reflects the absence of a clean earnings-growth trajectory. Net-net, valuation looks undemanding on cash-flow and asset metrics but not deeply discounted on forward earnings, leaving the re-rating case dependent on oil prices, merger execution, and the Eagle Ford sale.

PE

8.7x

Latest Quarter

vs. Historical

Mid-Range

5-Year PE Range 5x~13x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

4.0x

Enterprise Value Multiple

Investment Risk Disclosure

Financial and operational risks center on cash flow and liquidity. Q2 2026 free cash flow was -$373 million as capex of $4.047 billion exceeded operating cash flow of $3.674 billion, and the current ratio of 0.980 is below 1.0, indicating thin short-term liquidity. The company returned $366 million in dividends and $197 million in buybacks while repaying $500 million of debt, which is sustainable only if oil prices hold or asset sales materialize. Additionally, earnings are highly volatile: EPS swung from $0.19 in Q1 2026 to $2.04 in Q2 2026, and the forward PE of 9.46x above the trailing 8.70x implies the market expects earnings to normalize lower. Revenue concentration in the Permian (roughly two-thirds of production) and a 73% oil/NGL mix expose results directly to crude price swings.

Market and competitive risks include valuation compression if oil prices decline, given the stock's 53.68% one-year gain and position at 97.5% of its 52-week range. Beta of 0.536 suggests lower market correlation, but commodity-driven gap risk remains, as evidenced by the 22.7% max drawdown. The failed $4.5 billion Eagle Ford sale to BP weakens Devon's negotiating position with activists and highlights the difficulty of U.S. shale asset sales amid geopolitical uncertainty. Competitive pressure from larger integrated majors and other shale producers could limit Devon's ability to command premium valuations, and the pending Coterra merger introduces integration risk and share dilution (share count rose from 635 million to 937 million).

Worst-case scenario: a sharp decline in oil prices (e.g., if U.S.-Iran tensions ease or global demand weakens) combined with disappointment on asset sales and merger integration would compress cash flow and force Devon to cut capital returns. In this scenario, the stock could retrace to its 52-week low of $31.65, representing a -38.4% decline from the current $51.39. The analyst low target of $44.00 implies a -14.4% downside, but a more severe commodity downturn could push shares below that level toward the $40-$42 support base or lower. Investors should be prepared for a potential 15-40% drawdown in an adverse scenario.

FAQ

The key risks are: (1) Financial risk: negative free cash flow of -$373 million in Q2 2026 and a current ratio of 0.980 below 1.0, which could strain liquidity if oil prices fall. (2) Commodity price risk: a 73% oil/NGL mix means revenue and cash flow are highly sensitive to crude prices; a decline below $65/bbl could pressure the dividend and buyback. (3) Execution risk: the failed $4.5 billion Eagle Ford sale to BP weakens deleveraging prospects, and the Coterra merger integration (share count rose from 635 million to 937 million) carries dilution and synergy risks. (4) Valuation/momentum risk: the stock is up 53.68% over one year and sits 2.5% below its 52-week high, making it vulnerable to profit-taking; the 22.7% max drawdown shows downside volatility.

The 12-month forecast has three scenarios: Bull case (30% probability) targets $61.50-$74.00, assuming oil above $80/bbl, successful Coterra integration, and Eagle Ford sale completion. Base case (50% probability) targets $52.71-$61.50, assuming oil at $70-$80/bbl and gradual merger synergies. Bear case (20% probability) targets $31.65-$44.00, assuming oil below $65/bbl and asset sale disappointment. The base case is most likely, with the key assumption being stable oil prices around $75/bbl and no major integration setbacks. The analyst average target of $61.50 aligns with the upper end of the base case.

DVN appears fairly valued to slightly undervalued on cash flow and asset metrics. EV/EBITDA of 4.02x is at the low end of its historical 12.5x-32.0x band, PS of 1.34x is far below the 4.6x-9.3x range from 2022-2025, and PB of 1.48x is near the low end of its 0.93x-4.17x multi-year band. However, the trailing PE of 8.70x is mid-range relative to its own history (5.06x-66.2x), and the forward PE of 9.46x is above the trailing, implying the market expects earnings to normalize lower. The market is not paying a premium multiple, but the valuation implies expectations of stable-to-lower earnings and successful merger integration.

From a risk/reward perspective, DVN offers a favorable setup with +19.7% upside to the analyst average target of $61.50 and a high target of $74.00 (+44.0%), against a downside to the analyst low of $44.00 (-14.4%) and a 52-week low of $31.65 (-38.4%). The stock trades at an undemanding 4.02x EV/EBITDA and 1.34x PS, well below historical ranges, while the 26-analyst consensus is 'strong_buy' with a mean rating of 1.25. However, negative free cash flow of -$373 million in Q2 2026 and a current ratio below 1.0 are concerns. It is a good buy for value-oriented investors with a medium-term horizon who believe oil prices will remain elevated and merger synergies will materialize, but it may not suit risk-averse investors given commodity volatility.

DVN is suitable for both, but with different approaches. For long-term investors, the low beta of 0.536, 2.69% dividend yield, and deep inventory of Permian acreage support a buy-and-hold strategy with a minimum holding period of 2-3 years to capture merger synergies and commodity cycles. For short-term traders, the strong momentum (+53.68% one-year, relative strength +40.55 points vs. SPY) and well-defined technical levels (resistance at $52.71, support at $40-$42) offer trading opportunities, but the 22.7% max drawdown and commodity gap risk require tight risk management. A suggested minimum holding period for long-term investors is 12-18 months to allow the Coterra merger to close and synergies to be realized.